Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Teijin licenses new thrombolytic from Schering AG

Nov. 5, 1997

Factor Xa inhibitors prepared at DuPont Merck

Nov. 4, 1997

New orally active thrombin inhibitors from Merck & Co.

Nov. 3, 1997

Ortho discloses peptide serine protease inhibitors

Oct. 30, 1997

Advisory committee recommends approval for Plavix

Oct. 29, 1997

New serine protease inhibitors for thrombotic disorders from Akzo Nobel

Oct. 29, 1997

Factor Xa inhibitors from Zeneca for use as anticoagulants/antithrombotics

Oct. 27, 1997

Patents issued to Corvas for serine protease inhibitors

Oct. 22, 1997

Gensia receives FDA approval for desmopressin acetate injection

Oct. 21, 1997

Two large trials support use of alteplase accelerated infusion for acute MI

Oct. 20, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...